Word: synthes
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...icon (“Donovan”) and a family tragedy (“Grandbag’s Funeral”) before “Loose Fit,” a grooving tribute to the rave movement as fitting as any hedonistic hippie anthem. Over a repeated synth line and low, jazzy percussion, Ryder maps out the loose-fit aesthetic and the ethos of the accompanying rave scene as the album shifts to depictions of the loosely-fit’s high life, with the buoyancy of stand-out “Dennis and Lois” countered...
...they don’t seem to belong in the present, nor do they line up with any epoch of rock’s past. “Counting Down the Hours” enters in with brushed guitar and quiet vocals before swing-time guitars and a chiming synth line make Leo show off his range and force. His pedigree in punk shines through when he is forced to sing over loud guitar parts, and his vocals are easily the strength of the album. “Little Dawn” is a nearly six-minute treat, with...
...trade ideas with their German counterparts. But watch what they do, not what they say: officials on both sides say the move is largely an attempt to patch up bad feelings in Germany over recent French market interventions. Berlin was openly critical of France 's active support for Sanofi-Synthélabo's takeover of Franco-German drug firm Aventis. And as it seeks to bail out ailing engineering company Alstom , France so far is blocking Germany 's Siemens from acquiring divisions...
...Moscow-based Renaissance Capital, says the move is simply "papering over cracks." Still, Gerashchenko is expected to be elected chairman after shareholders meet in late June. Compensation Overdose? Igor Landau, the CEO of Franco-German drug company Aventis, fought off a hostile takeover attempt by France 's Sanofi-Synthélabo for three turbulent months. But he caved in last week and agreed...
...Speed limits vary. - By Adam Smith Hard To Swallow Swiss drugmaker Novartis accepted an invitation for merger talks from Franco-German Aventis. A deal won't be easy: the French government is against foreign ownership of Aventis, favoring the hostile €46 billion bid from its own Sanofi-Synthélabo...